GSK (GSK)
NYSE: GSK
· Real-Time Price · USD
39.22
0.09 (0.23%)
At close: Aug 14, 2025, 3:59 PM
38.88
-0.87%
Pre-market: Aug 15, 2025, 07:06 AM EDT
GSK Balance Sheet Statement
Financials in GBP. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 3.6B | 4.46B | 3.69B | 3.19B | 2.96B | 2.79B | 2.94B | 3.18B | 3.14B | 2.89B | 3.72B | 3.61B | 6.46B | 10.97B | 4.27B | 3.45B | 3.5B | 4.76B |
Short-Term Investments | 20M | 21M | 21M | 20M | 21M | 1.3B | 2.25B | 3.51B | 3.36B | 4.08B | 4.15B | 3.56B | 67M | 3.01B | 61M | 61M | 59M | 60M |
Long-Term Investments | n/a | 1.01B | 1.21B | 1.11B | 1.15B | 1.28B | 2.14B | -2.36B | -2.01B | -2.75B | -2.61B | -1.93B | 1.66B | -1.27B | 2.15B | 2.76B | 3.18B | 3.69B |
Other Long-Term Assets | 2.98B | 2.04B | 1.93B | 1.94B | 1.73B | 1.65B | 634M | 4.65B | 4.77B | 5.58B | 5.35B | 4.74B | 1.81B | 4.83B | 1.75B | 1.31B | 1.2B | 1.05B |
Receivables | 7.32B | 7.06B | 6B | 7.38B | 7.26B | 6.83B | 5.91B | 8.54B | 6.78B | 6.83B | 5.45B | 7.51B | 6.46B | 8.3B | 8.03B | 7.7B | 6.9B | 7.18B |
Inventory | 6.07B | 6B | 5.67B | 5.92B | 5.86B | 5.7B | 5.5B | 5.48B | 5.51B | 5.36B | 5.15B | 4.66B | 4.66B | 6B | 5.78B | 6.24B | 6.33B | 6.22B |
Other Current Assets | 661M | 541M | 1.23B | 785M | 663M | 577M | 1.2B | 533M | 556M | 556M | 1.1B | 921M | 36.53B | 708M | 1.36B | 799M | 772M | 999M |
Total Current Assets | 17.67B | 18.09B | 17B | 17.3B | 16.76B | 17.2B | 18.64B | 21.24B | 19.35B | 19.72B | 20.77B | 20.25B | 54.19B | 28.99B | 18.67B | 18.25B | 17.57B | 18.52B |
Property-Plant & Equipment | 9.92B | 9.97B | 10.07B | 9.72B | 9.82B | 9.87B | 9.96B | 9.45B | 9.31B | 9.41B | 9.62B | 9.65B | 9.15B | 10.7B | 10.67B | 10.67B | 10.59B | 10.63B |
Goodwill & Intangibles | 22.11B | 23.18B | 22.5B | 21.69B | 22.43B | 22.64B | 21.58B | 22.27B | 22.25B | 21.02B | 21.36B | 22.78B | 17.28B | 41.17B | 40.63B | 40.82B | 39.77B | 39.86B |
Total Long-Term Assets | 41.59B | 42.62B | 42.47B | 40.75B | 41.3B | 41.31B | 40.36B | 39.62B | 40.11B | 38.88B | 39.38B | 40.06B | 34.86B | 60.7B | 60.43B | 60.44B | 59.45B | 59.55B |
Total Assets | 59.26B | 60.7B | 59.46B | 58.05B | 58.07B | 58.51B | 59.01B | 60.86B | 59.46B | 58.6B | 60.15B | 60.31B | 89.05B | 89.69B | 79.1B | 78.69B | 77.01B | 78.08B |
Account Payables | 14.82B | 15.15B | 3.46B | 14.38B | 12.6B | 12.99B | 3.72B | 14.41B | 12.56B | 12.86B | 3.87B | 14.78B | 13.35B | 15.75B | 4.54B | 13.61B | 12.99B | 13.04B |
Deferred Revenue | n/a | n/a | n/a | n/a | 731M | 720M | 500M | 941M | 1.29B | n/a | n/a | n/a | n/a | n/a | 1.56B | 1.55B | 1.34B | 1.75B |
Short-Term Debt | n/a | 1.96B | 2.18B | 2.81B | 3.37B | 2.62B | 2.66B | 4.84B | 5.92B | 4.26B | 3.79B | 2.79B | 3.33B | 4.1B | 3.4B | 4.87B | 5.04B | 3.17B |
Other Current Liabilities | 4.98B | 3.1B | 14.76B | 3.7B | 3.65B | 3.52B | 1.74B | 2.85B | 3.09B | 3.15B | -1.84B | 3.25B | 20.86B | 3.64B | -2.84B | 3.23B | 2.95B | 3.4B |
Total Current Liabilities | 20.38B | 20.83B | 21.7B | 21.46B | 20.34B | 19.85B | 21.07B | 22.39B | 22.11B | 20.7B | 22.81B | 20.95B | 37.84B | 24.28B | 23.67B | 22.42B | 21.39B | 20.27B |
Long-Term Debt | n/a | 16.47B | 13.7B | 13.24B | 13.58B | 15.16B | 14.15B | 15.99B | 15.55B | 16.64B | 16.19B | 19.32B | 18.78B | 29.23B | 19.76B | 20.74B | 20.44B | 23.05B |
Other Long-Term Liabilities | 24.14B | 9.75B | 9.5B | 9.6B | 10.08B | 9.99B | 9.37B | 6.55B | 9.14B | 9.65B | 9.83B | 10.96B | 9.64B | 9.88B | 9.88B | 10.12B | 10.02B | 10.18B |
Total Long-Term Liabilities | 24.53B | 26.22B | 24.68B | 23.14B | 23.95B | 25.44B | 25.14B | 25.85B | 25.19B | 26.59B | 27.24B | 30.64B | 28.57B | 42.78B | 34.09B | 34.52B | 34.05B | 36.79B |
Total Liabilities | 44.9B | 47.05B | 46.38B | 44.6B | 44.3B | 45.28B | 46.21B | 48.24B | 47.3B | 47.28B | 50.05B | 51.6B | 66.41B | 67.06B | 57.76B | 56.94B | 55.43B | 57.07B |
Total Debt | n/a | 18.43B | 16.99B | 16.06B | 16.94B | 17.77B | 18.02B | 20.84B | 21.47B | 20.91B | 20.99B | 22.11B | 22.11B | 33.33B | 24.17B | 25.61B | 25.48B | 26.22B |
Common Stock | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B | 1.35B |
Retained Earnings | 8.8B | 8.31B | 7.8B | 8.19B | 8.58B | 7.93B | 7.24B | 7.02B | 6.42B | 5.66B | 4.36B | 2.59B | 9.82B | 9.64B | 7.94B | 7.78B | 7.38B | 6.7B |
Comprehensive Income | n/a | 1.02B | 83M | 1B | 969M | 1.09B | 1.6B | 1.32B | 1.48B | 1.37B | -48M | 1.77B | 1.76B | 1.76B | 642M | 3B | 3.44B | 3.52B |
Shareholders Equity | 14.79B | 14.16B | 13.67B | 14.01B | 14.37B | 13.84B | 13.35B | 13.13B | 12.69B | 11.82B | 10.6B | 9.15B | 16.37B | 16.18B | 15.05B | 15.43B | 15.38B | 14.87B |
Total Investments | 977M | 1.03B | 1.23B | 1.12B | 1.17B | 2.58B | 4.39B | 1.14B | 1.35B | 1.34B | 1.54B | 1.63B | 1.73B | 1.74B | 2.21B | 2.82B | 3.23B | 3.75B |